Nouveaux guidelines
Sept nouveaux guidelines : Nutrition (ESPEN), Gastric Cancer, eUpdate – Hepatocellular Carcinoma, Liver Biopsy, Probiotics, Sedation in Endoscopy, Diverticulite. Retrouvez tous les guidelines dans notre rubrique Practice Guidelines.
Alerte Covid-19 et UEG : ressources
Le site de l’UEG consacre une page de son site internet aux ressources pertinentes pour les professionnels de la santé digestive. https://ueg.eu/p/153 « La propagation rapide du roman Coronavirus Disease 2019… Lire la suite
Alerte Covid-19 : recommandations EASL-ESCMID
EASL-ESCMID Position Paper : L’Association européenne pour l’étude du foie (EASL) et la Société européenne de microbiologie clinique et des maladies infectieuses (ESCMID) ont publié ce 2 avril 2020 un… Lire la suite
Alerte Covid-19 et endoscopies
Recommandations de la BSG concernant les endoscopies et le Coronavirus GI Endoscopy Activity and COVID-19: Next steps – Last Modified 26th March 2020 v2.1 https://www.bsg.org.uk/covid-19-advice/gi-endoscopy-activity-and-covid-19-next-steps/ Recommandations de la SFED,… Lire la suite
Alerte Covid-19 et soins ambulatoires privés
Nous vous invitons à prendre connaissance des recommandations du SPF Santé publique concernant:l’utilisation des masques buccaux et la procédure pour les soins ambulatoires en cabinet privé. Utilisation des masques buccaux… Lire la suite
We are looking forward to connect with you - Join us for a full day on endoscopy on Monday, September 21, 2020 at ESGE Connect!
The event will be 100% free and 100% online - Check out the full scientific programme and register now !
esgeconnect2020.vfairs.com/en/
11 août, 14:32
Join Massimo Colombo & Nina Weis for The Digital International Liver Congress ™ 2020 session dedicated to #HCV Long-term management.
Abstracts presented:
- The dynamics of FIB4 after sustained viral response predicts the risk of liver-related complication in HCV cirrhosis (ANRS CO12 CirVir)
- Non-invasive monitoring of liver disease regression in patients with advanced chronic liver disease after sustained virologic response to INF-free therapies
- HIV co-infection and risk of morbidity and mortality in HCV patients treated by DAA
- Predictive models for hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C and sustained virological response (SVR) achieved with direct acting anti-viral (DAA) included in the ANRS C022 HEPATHER cohort
- A simple score for HCC risk stratification in CHC patients with cirrhosis or advanced hepatic fibrosis who achieved SVR following DAA therapy
- Virological characterization of patients with chronic hepatitis C and failure to a Glecaprevir/Pibrentasvir or Voxilaprevir/Velpatasvir/Sofosbuvir treatment in the International SHARED collaboration
Only 1⃣6⃣ days left to register bit.ly/Register-Digital-ILC
11 août, 10:54
We’re happy to announce that we will have again this year a session at the European Health Forum Gastein! Our event, themed ‘Science of healthy living’, will take place on September 30, between 16:30-18:00. Check out the official programme of #EHFG2020!
bit.ly
The determinants of health and well-being are often driven by the interests of big players, which are not always aligned with public health agendas. In order to purposefully engage with these giants w...11 août, 10:00